Active Video Games to Promote Physical Activity in Children With Cancer

• Sponsor: Turku University Hospital (Other)
• Overall Status: Completed
• CT.gov ID: NCT01748058
• Collaborator: University of Turku (Other), Tampere University Hospital (Other)
• Enrollment: 36
• Location: 1
• Arms: 2
• Actual Duration (Months): 53.9
• Patients Per Site Per Month: 0.7

Study Details

Study Description

Brief Summary

The aim of this study is to evaluate the efficacy and feasibility of active video gaming with regard to the promotion of physical activity and motor learning in children with cancer. Experienced fatigue, body mass index and the development of metabolic risk factors during treatment are also examined.

Condition or Disease	Intervention/Treatment	Phase
Cancer	Behavioral: Exercise based on active video gaming	N/A

Study Design

• Study Type: Interventional
• Actual Enrollment: 36 participants
• Allocation: Randomized
• Intervention Model: Parallel Assignment
• Masking: None (Open Label)
• Primary Purpose: Prevention
• Official Title: Active Video Games to Promote Physical Activity, Motor Performance and Quality of Life in Children With Cancer: an Intervention Study With 2-year Follow-up
• Actual Study Start Date: Jan 1, 2013
• Actual Primary Completion Date: Jul 1, 2017
• Actual Study Completion Date: Jul 1, 2017

Arms and Interventions

Arm	Intervention/Treatment
Experimental: Active video games Exercise based on active video gaming	Behavioral: Exercise based on active video gaming
No Intervention: Routine care

Outcome Measures

Primary Outcome Measures

1. Accelerometer, average counts of dynamic acceleration (physical activity) [1 week at baseline and at 12 months]

   Change in the children's physical activity levels with accelerometer

Secondary Outcome Measures

1. Movement assessment battery for children (M-ABC-2) scores (motor performance) [At baseline, 2, 6, 12 and 24 months]

   Change in M-ABC scores

2. PedsQL Multidimensional Fatigue Scale scores (fatigue) [At baseline, 2, 6, 12 and 24 months]

   Change in experienced fatigue

3. Blood sugar [At baseline, 2, 6, 12 and 24 months]

   Change in blood sugar

4. Blood insulin [At baseline, 2, 6, 12 and 24 months]

   Change in blood insulin

Eligibility Criteria

Criteria

• Ages Eligible for Study: 3 Years to 16 Years
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• cancer diagnose

• treated with Vincristine in Turku University Hospital or Tampere University Hospital

Exclusion Criteria:

• other diseases limiting functional ability

• not able to communicate

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Turku University Hospital	Turku		Finland

Sponsors and Collaborators

• Turku University Hospital
• University of Turku
• Tampere University Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

• Study protocol
• Results

Publications

None provided.

• Responsible Party: Päivi Lähteenmäki, MD, PhD, Turku University Hospital
• ClinicalTrials.gov Identifier: NCT01748058
• Other Study ID Numbers: T87/2012
• First Posted: Dec 12, 2012
• Last Update Posted: Dec 23, 2019
• Last Verified: Dec 1, 2019

Study Results

No Results Posted as of Dec 23, 2019